Clinical Trials Directory

Trials / Completed

CompletedNCT02292342

An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy Men

An Acute, Double-blind, Randomised, Placebo-controlled, Crossover Intervention Trial Investigating the Dose-dependent Vascular Effects of Pure (-)-Epicatechin (≤1 mg/kg BW) in Healthy Men.

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Reading · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Aim: To investigate the dose-dependent vascular effect (primarily using FMD) of 3 low-level doses of pure (-)-epicatechin ≤ 1 mg/kg BW (0.1, 0.5 \& 1.0 mg/kg BW) in healthy men.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWaterControl
DIETARY_SUPPLEMENTEpicatechin 0.1 mg/kgEC 0.1 mg/kg
DIETARY_SUPPLEMENTEpicatechin 0.5 mg/kgEC 0.5
DIETARY_SUPPLEMENTEpicatechin 1.0 mg/kgEC 1.0

Timeline

Start date
2014-05-01
Primary completion
2016-02-01
Completion
2016-05-01
First posted
2014-11-17
Last updated
2016-05-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02292342. Inclusion in this directory is not an endorsement.

An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy Men (NCT02292342) · Clinical Trials Directory